Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation

Elevated levels of erythropoietin (EPO) are associated with an increased risk of death in renal transplant recipients (RTRs), but the underlying mechanisms remain unclear. Emerging data suggest that EPO stimulates production of the phosphaturic hormone fibroblast growth factor 23 (FGF23), another st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Med
Auteurs principaux: Eisenga, Michele F., De Jong, Maarten A., Leaf, David E., Nolte, Ilja M., De Borst, Martin H., Bakker, Stephan J. L., Gaillard, Carlo A. J. M.
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356141/
https://ncbi.nlm.nih.gov/pubmed/32512806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061737
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires